NDT Financial Statements From 2010 to 2025
| NDTP Stock | USD 1.50 0.40 21.05% |
Check NDT Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NDT Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . NDT financial statements analysis is a perfect complement when working with NDT Pharmaceuticals Valuation or Volatility modules.
NDT |
NDT Pharmaceuticals Company Current Valuation Analysis
NDT Pharmaceuticals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current NDT Pharmaceuticals Current Valuation | 123.75 K |
Most of NDT Pharmaceuticals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NDT Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, NDT Pharmaceuticals has a Current Valuation of 123.75 K. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
NDT Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NDT Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare NDT Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NDT Pharmaceuticals competition to find correlations between indicators driving NDT Pharmaceuticals's intrinsic value. More Info.NDT Pharmaceuticals is rated below average in current valuation category among its peers. It is rated below average in shares outstanding category among its peers creating about 9.09 of Shares Outstanding per Current Valuation. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NDT Pharmaceuticals' earnings, one of the primary drivers of an investment's value.About NDT Pharmaceuticals Financial Statements
NDT Pharmaceuticals shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although NDT Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in NDT Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on NDT Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. Ndt Pharmaceuticals is traded on OTC Exchange in the United States.
Pair Trading with NDT Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NDT Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NDT Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against NDT Pink Sheet
The ability to find closely correlated positions to NDT Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NDT Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NDT Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NDT Pharmaceuticals to buy it.
The correlation of NDT Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NDT Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NDT Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NDT Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for NDT Pink Sheet Analysis
When running NDT Pharmaceuticals' price analysis, check to measure NDT Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NDT Pharmaceuticals is operating at the current time. Most of NDT Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NDT Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NDT Pharmaceuticals' price. Additionally, you may evaluate how the addition of NDT Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.